INTERMEDIATE EVALUATION OF VIVOPTIM - THE MGEN (FRENCH INSURER) PREVENTION PROGRAM FOR CARDIOVASCULAR RISKS
Author(s)
Blachier M1, Vimont A1, Ballouk S2, Le Lann A2, Femery V2
1PUBLIC HEALTH EXPERTISE, Paris, France, 2MGEN, Paris, France
Presentation Documents
OBJECTIVES: VIVOPTIM is an innovative prevention program for cardiovascular (CV) risks designed and financed by the French insurer MGEN Union. It is a personalized program based on digital services, telemedicine devices and direct coaching. A pilot program was launched in 2015 in two French regions (Midi Pyrénées and Bourgogne). A total of 15 different prevention programs were proposed: obesity, atherosclerosis, hypertension, physical activity… based on their CV risk profile. An evaluation of VIVOPTIM after 10 months of follow up was conducted. METHODS: The clinical data collected longitudinally and routinely during the program was described and analyzed. Evolution of risk factors between ‘highly active’ participants and ‘weakly active’ participants were compared with univariate and multivariate analyses. The participation was measured by the time spent with a coach or connected to the web platform. VIVOPTIM results were compared with results of other published prevention programs. RESULTS: CONCLUSIONS: VIVOPTIM shows similar efficacy results as already published programs. Extrapolation of these results with standard risk scores (SCORE and Framingham equations) shows that this pilot program conducted in two regions could have avoided 29 cardiovascular events.
Conference/Value in Health Info
2017-11, ISPOR Europe 2017, Glasgow, Scotland
Value in Health, Vol. 20, No. 9 (October 2017)
Code
PCV133
Topic
Health Service Delivery & Process of Care
Topic Subcategory
Treatment Patterns and Guidelines
Disease
Cardiovascular Disorders